It was stated that the hyaluronan synthesis inhibitor 4-methylumbelliferone (4Mu) could induce a potent anti-cancer efficacy in HCC by targeting the CD47+ CSCs [137]. The gene discussed is CD47; the disease is hepatocellular carcinoma.